Search results
Results from the WOW.Com Content Network
[9] [10] [11] In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. [12] It is a leader in the FTSE4Good Index, and the only European company in the top ten. [13] Novo Nordisk is the largest pharmaceutical company in ...
Insulin aspart, sold under the brand name NovoLog, among others, is a modified type of medical insulin used to treat type 1 and type 2 diabetes. [17] It is generally used by injection under the skin but may also be used by injection into a vein. [17] Maximum effect occurs after about 1–3 hours and lasts for 3–5 hours. [17]
The long acting insulin is given once (usually glargine, Lantus) or twice (usually detemir, Levemir) daily to provide a base, or basal insulin level. Rapid acting (RA) insulin is given before meals and snacks. A similar profile can be provided using an insulin pump where rapid acting insulin is given as the basal and premeal bolus insulin.
Regular insulin can be made from the pancreas of pigs or cows. [2] Human versions can be made either by modifying pig versions or recombinant technology. [2] Insulin was first used as a medication in Canada by Charles Best and Frederick Banting in 1922. [7] It is on the World Health Organization's List of Essential Medicines. [8]
Novo Holdings A/S (formerly Novo A/S) [1] is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S.Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion [2] [3] [4] Danish Kroner (approximately US$163 billion).
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
An insulin analog (also called an insulin analogue) is any of several types of medical insulin that are altered forms of the hormone insulin, different from any occurring in nature, but still available to the human body for performing the same action as human insulin in terms of controlling blood glucose levels in diabetes.
It works by increasing the amount of glucose that tissues take in and decreasing the amount of glucose made by the liver. [6] Insulin detemir was approved for medical use in the European Union in June 2004, and in the United States in June 2005. [5] [6] [8] It is on the World Health Organization's List of Essential Medicines. [9]